Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
TransMedics Group, Inc. (TMDX) had Free Cash Flow per Share of $-2.30 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$441.54M |
|
$35.46M |
|
$179.46M |
|
$262.08M |
|
$404.04M |
|
$37.50M |
|
$-1.72M |
|
$35.78M |
|
$35.78M |
|
$35.46M |
|
$35.46M |
|
$35.46M |
|
$35.46M |
|
$37.50M |
|
$57.25M |
|
33.23M |
|
35.22M |
|
$1.07 |
|
$1.01 |
|
| Balance Sheet Financials | |
$497.22M |
|
$285.97M |
|
$306.86M |
|
$804.08M |
|
$59.91M |
|
$509.31M |
|
$515.56M |
|
$575.47M |
|
$228.60M |
|
$214.90M |
|
$228.60M |
|
33.62M |
|
| Cash Flow Statement Financials | |
$48.80M |
|
$-129.30M |
|
$22.87M |
|
$395.31M |
|
$337.15M |
|
$-58.16M |
|
$33.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.30 |
|
-- |
|
-- |
|
0.69 |
|
2.23 |
|
59.36% |
|
8.49% |
|
8.49% |
|
12.97% |
|
8.10% |
|
8.03% |
|
$-80.94M |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
3.85 |
|
4.52 |
|
80.78 |
|
15.51% |
|
16.50% |
|
4.41% |
|
4.81% |
|
$6.80 |
|
|
Free Cash Flow per Share |
$-2.30 |
$1.39 |
|